Equitec Specialists’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History

Equitec Specialists’s Portfolio APDNW Stock Details APDNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-70,000	Closed	-$73K	–	111
2015 Q1	$73K	Hold	70,000	–	–	0.02%	74
2014 Q4	$85K	Buy	+70,000	New	+$69.2K	0.02%	73

Other funds holding APDNW

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

ICM

Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Equitec Specialists's APDNW Position: Q2 2015 in Review

Equitec Specialists sold out of Applied DNA Sciences Inc Warrant (APDNW) in Q2 2015, closing a stake of 70,000 shares — an estimated $73K sold.

Equitec Specialists first reported a position in APDNW in Q4 2014 and held it in 2 quarters. The position peaked at $85K in Q4 2014. 7 funds tracked by Wall St. Rank hold APDNW as of Q2 2015.

Equitec Specialists reported no remaining Applied DNA Sciences Inc Warrant position as of Q2 2015 after selling out during the quarter.
Equitec Specialists sold 70,000 Applied DNA Sciences Inc Warrant shares in Q2 2015, an estimated $73K.
Equitec Specialists first reported a position in Applied DNA Sciences Inc Warrant in Q4 2014 and held it in 2 quarters.
Equitec Specialists's Applied DNA Sciences Inc Warrant position peaked at $85K in Q4 2014.
7 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q2 2015.

Based on Equitec Specialists's 13F filing for Q2 2015, filed 5 Aug 2015.